GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹6,788 Cr | ₹6,015 Cr | ₹5,234 Cr | ₹4,023 Cr | ₹3,026 Cr |
What is the latest Profit & Loss Account Balance ratio of GLAND PHARMA ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹6,788 Cr |
Mar2023 | ₹6,015 Cr |
Mar2022 | ₹5,234 Cr |
Mar2021 | ₹4,023 Cr |
Mar2020 | ₹3,026 Cr |
How is Profit & Loss Account Balance of GLAND PHARMA Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹6,788 Cr | 12.84 | |
Mar2023 | ₹6,015 Cr | 14.92 | |
Mar2022 | ₹5,234 Cr | 30.12 | |
Mar2021 | ₹4,023 Cr | 32.95 | |
Mar2020 | ₹3,026 Cr | - |
Compare Profit & Loss Account Balance of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹32,303.3 Cr | -0.5% | 12.4% | 1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,620.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,571.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | -0.5% |
12.4% |
1% |
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses